These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

427 related items for PubMed ID: 25618409

  • 1. Cardiomyocyte-specific expression of CYP2J2 prevents development of cardiac remodelling induced by angiotensin II.
    He Z, Zhang X, Chen C, Wen Z, Hoopes SL, Zeldin DC, Wang DW.
    Cardiovasc Res; 2015 Mar 01; 105(3):304-17. PubMed ID: 25618409
    [Abstract] [Full Text] [Related]

  • 2. CYP2J2 overexpression attenuates nonalcoholic fatty liver disease induced by high-fat diet in mice.
    Chen G, Xu R, Zhang S, Wang Y, Wang P, Edin ML, Zeldin DC, Wang DW.
    Am J Physiol Endocrinol Metab; 2015 Jan 15; 308(2):E97-E110. PubMed ID: 25389366
    [Abstract] [Full Text] [Related]

  • 3. Sialyltransferase7A promotes angiotensin II-induced cardiomyocyte hypertrophy via HIF-1α-TAK1 signalling pathway.
    Yan X, Zhao R, Feng X, Mu J, Li Y, Chen Y, Li C, Yao Q, Cai L, Jin L, Han C, Zhang D.
    Cardiovasc Res; 2020 Jan 01; 116(1):114-126. PubMed ID: 30854566
    [Abstract] [Full Text] [Related]

  • 4. Choline ameliorates cardiac hypertrophy by regulating metabolic remodelling and UPRmt through SIRT3-AMPK pathway.
    Xu M, Xue RQ, Lu Y, Yong SY, Wu Q, Cui YL, Zuo XT, Yu XJ, Zhao M, Zang WJ.
    Cardiovasc Res; 2019 Mar 01; 115(3):530-545. PubMed ID: 30165480
    [Abstract] [Full Text] [Related]

  • 5. CYP epoxygenase 2J2 prevents cardiac fibrosis by suppression of transmission of pro-inflammation from cardiomyocytes to macrophages.
    Yang L, Ni L, Duan Q, Wang X, Chen C, Chen S, Chaugai S, Zeldin DC, Tang JR, Wang DW.
    Prostaglandins Other Lipid Mediat; 2015 Mar 01; 116-117():64-75. PubMed ID: 25686540
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Epoxyeicosatrienoic acid prevents maladaptive remodeling in pressure overload by targeting calcineurin/NFAT and Smad-7.
    Li X, Chu G, Zhu F, Zheng Z, Wang X, Zhang G, Wang F.
    Exp Cell Res; 2020 Jan 01; 386(1):111716. PubMed ID: 31734152
    [Abstract] [Full Text] [Related]

  • 11. CYP2J2 and its metabolites (epoxyeicosatrienoic acids) attenuate cardiac hypertrophy by activating AMPKα2 and enhancing nuclear translocation of Akt1.
    Wang B, Zeng H, Wen Z, Chen C, Wang DW.
    Aging Cell; 2016 Oct 01; 15(5):940-52. PubMed ID: 27416746
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. BMP-7 attenuates left ventricular remodelling under pressure overload and facilitates reverse remodelling and functional recovery.
    Merino D, Villar AV, García R, Tramullas M, Ruiz L, Ribas C, Cabezudo S, Nistal JF, Hurlé MA.
    Cardiovasc Res; 2016 Jun 01; 110(3):331-45. PubMed ID: 27068510
    [Abstract] [Full Text] [Related]

  • 15. Aspirin Attenuates Angiotensin II-induced Cardiomyocyte Hypertrophy by Inhibiting the Ca(2+)/Calcineurin-NFAT Signaling Pathway.
    Yin Z, Wang X, Zhang L, Zhou H, Wei L, Dong X.
    Cardiovasc Ther; 2016 Feb 01; 34(1):21-9. PubMed ID: 26506219
    [Abstract] [Full Text] [Related]

  • 16. CYP2J2 and EETs protect against lung ischemia/reperfusion injury via anti-inflammatory effects in vivo and in vitro.
    Chen W, Yang S, Ping W, Fu X, Xu Q, Wang J.
    Cell Physiol Biochem; 2015 Feb 01; 35(5):2043-54. PubMed ID: 25870948
    [Abstract] [Full Text] [Related]

  • 17. Stachydrine hydrochloride suppresses phenylephrine-induced pathological cardiac hypertrophy by inhibiting the calcineurin/nuclear factor of activated T-cell signalling pathway.
    Zheng J, Tian J, Wang S, Hu P, Wu Q, Shan X, Zhao P, Zhang C, Guo W, Xu M, Chen H, Lu R.
    Eur J Pharmacol; 2020 Sep 15; 883():173386. PubMed ID: 32712088
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Activation of peroxisome proliferator-activated receptor γ (PPARγ) through NF-κB/Brg1 and TGF-β1 pathways attenuates cardiac remodeling in pressure-overloaded rat hearts.
    Qi HP, Wang Y, Zhang QH, Guo J, Li L, Cao YG, Li SZ, Li XL, Shi MM, Xu W, Li BY, Sun HL.
    Cell Physiol Biochem; 2015 Sep 15; 35(3):899-912. PubMed ID: 25633415
    [Abstract] [Full Text] [Related]

  • 20. CYP2J2-derived epoxyeicosatrienoic acids suppress endoplasmic reticulum stress in heart failure.
    Wang X, Ni L, Yang L, Duan Q, Chen C, Edin ML, Zeldin DC, Wang DW.
    Mol Pharmacol; 2014 Jan 15; 85(1):105-15. PubMed ID: 24145329
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.